Subtype
Inflammatory Myofibroblastic Tumor
CI-CAN-00002917IMTExplore in graph →
Non-malignant2 active trials10 evidence items
Loading cancer entity…
Subtype
CI-CAN-00002917IMTExplore in graph →
Clinical trials
7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05160922 | Crizotinib Continuation Clinical Study | active not recruiting | Phase 4 | 27 | PfizerINDUSTRY | 5 | Mar 30, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Mar 30, 2026source: clinicaltrials